Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer


SAN JOSE, Calif., Oct. 11, 2019 /PRNewswire/ — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that it has appointed Paul…


Author: HEDGE

Executive Editor and Founder of Hedge Was Founded in January 22, 2008. Learn more about HEDGEaccordingly